BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gonçalves LL, Farias AQ, Gonçalves PL, D’Amico EA, Carrilho FJ. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. World J Gastroenterol 2006; 12(28): 4602-4603 [PMID: 16874884 DOI: 10.3748/wjg.v12.i28.4602]
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4602.htm
Number Citing Articles
1
Adil Jaulim, Badia Ahmed, Tina Khanam, Irini P. Chatziralli. BRANCH RETINAL VEIN OCCLUSIONRetina 2013; 33(5): 901 doi: 10.1097/IAE.0b013e3182870c15
2
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot, Alexa Simon Meara. Ocular side effects of antirheumatic medications: a qualitative reviewBMJ Open Ophthalmology 2020; 5(1): e000331 doi: 10.1136/bmjophth-2019-000331
3
A. Such Díaz, N. Barrueco, C. Esteban Alba, I. Escobar Rodríguez. Trombosis venosa retiniana asociada a peginterferón alfa 2b más ribavirina en un paciente con hepatitis C crónicaFarmacia Hospitalaria 2011; 35(2): 93 doi: 10.1016/j.farma.2010.01.010
4
Wenlan Zhang, Paul Hahn. Handbook of Venous Thromboembolism2017; : 216 doi: 10.1002/9781119095606.ch24
5
David J. Browning. Retinal Vein Occlusions2012; : 125 doi: 10.1007/978-1-4614-3439-9_6
6
Mehrdad Afarid, Hamid Lashkarizadeh, MohammadJ Ashraf, MohammadHossein Nowroozzadeh, SayedM Shafiee. The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitisIndian Journal of Ophthalmology 2016; 64(5): 376 doi: 10.4103/0301-4738.185605
7
A. Viennet, F. Glatre, F. Bacin. Rétinopathie à interferon alpha 2b et ribavirine chez un patient atteint d’une hépatite C chroniqueJournal Français d'Ophtalmologie 2009; 32(7): 505 doi: 10.1016/j.jfo.2009.04.007
8
J.J. Napal Lecumberri, C. Sedano Balbas, J. Cañal Villanueva, J.L. Hernández Hernández. Thrombophilia and vascular risk factors in retinal vein occlusionRevista Clínica Española (English Edition) 2013; 213(5): 229 doi: 10.1016/j.rceng.2013.05.002
9
I. Sanlés González, J.J. Napal Lecumberri, R. Pérez-Montes, A. Cerveró Varona, A. Casado Rojo, J.L. Hernández Hernández. Oclusión venosa retiniana en pacientes menores de 50 años. Análisis de factores de riesgo vascular, trombofilia, hallazgos ecográficos carotídeos y etiologías poco frecuentesArchivos de la Sociedad Española de Oftalmología 2022; 97(8): 443 doi: 10.1016/j.oftal.2021.12.003
10
Matthew Driban, Nikita Kedia, Supriya Arora, Jay Chhablani. Novel pharmaceuticals for the management of retinal vein occlusion and linked disordersExpert Review of Clinical Pharmacology 2023; 16(11): 1125 doi: 10.1080/17512433.2023.2277882
11
Ligita Jancoriene, Dovile Norvydaite, Saulius Galgauskas, Evelina Balciunaite. Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and RibavirinHepatitis Monthly 2014; 14(2) doi: 10.5812/hepatmon.15124
12
Yong Dae Kwon, Ji Won Lim. Clinical Features of Retinopathy in Chronic Hepatitis B Patients With Treated With PeginterferonJournal of the Korean Ophthalmological Society 2011; 52(1): 41 doi: 10.3341/jkos.2011.52.1.41
13
Michael R Narkewicz, Philip Rosenthal, Kathleen B Schwarz, Arlene Drack, Todd Margolis, Michael X Repka. Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated InterferonJournal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 183 doi: 10.1097/MPG.0b013e3181b99cf0
14
Joon Hyung Yeo, Kyoung Woo Kim, Jae Chan Kim. Mooren’s ulcerative keratitis after systemic pegylated interferon alpha2a in chronic hepatitis CCanadian Journal of Ophthalmology 2017; 52(5): e163 doi: 10.1016/j.jcjo.2017.03.018
15
Chia-Hsiang Shih, Shu-Yu Ou, Chia-Jen Shih, Yung-Tai Chen, Shuo-Ming Ou, Yi-Jung Lee. Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: A nationwide population-based studyInternational Journal of Cardiology 2015; 178: 256 doi: 10.1016/j.ijcard.2014.10.110
16
Sohan Singh Hayreh. Ocular Vascular Occlusive Disorders2015; : 771 doi: 10.1007/978-3-319-12781-1_26
17
Hassan Seddik, Mouna Tamzaourte, Fadoua Rouibaa, Maha Fadlouallah, Ahmed Benkirane. Irreversible Anterior Ischemic Optic Neuropathy Complicating Interferon Alpha and Ribaverin TherapyInternational Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/814242
18
L. De Simone, P. Gentile, R. Aldigeri, V. Mastrofilippo, E. Bolletta, F. Gozzi, C. Adani, C. Salvarani, L. Cimino. Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated InterferonOcular Immunology and Inflammation 2024; 32(5): 678 doi: 10.1080/09273948.2023.2195494
19
Javier S. Martinez de Aragon, Jose S. Pulido, Christopher L. Haupert, Christopher F. Blodi, Jared S. Nielsen, Lee M. Jampol. INTERFERON-β–ASSOCIATED RETINOPATHYRETINAL Cases & Brief Reports 2009; 3(1): 24 doi: 10.1097/ICB.0b013e31814b160d
20
Hee Young Kang, Min Chul Shin. Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic HepatitisKorean Journal of Ophthalmology 2012; 26(2): 147 doi: 10.3341/kjo.2012.26.2.147
21
N. Kabbaj, S. Sentissi, M. Mohammadi, A. Benaïssa, N. Amrani. Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisCGastroentérologie Clinique et Biologique 2009; 33(2): 115 doi: 10.1016/j.gcb.2008.12.004
22
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi, Jay Chhablani. Retinal toxicities of systemic anticancer drugsSurvey of Ophthalmology 2022; 67(1): 97 doi: 10.1016/j.survophthal.2021.05.007
23
Yi-Hsuan Wei, I-Hua Wang, Lin-Chung Woung, Jieh-Ren Jou. Anterior Ischemic Optic Neuropathy Associated with Pegylated Interferon Therapy for Chronic Hepatitis COcular Immunology and Inflammation 2009; 17(3): 191 doi: 10.1080/09273940802687820
24
Masaaki Watanabe, Sumie Ogasawara, Akihiko Takahashi, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Wasaburo Koizumi. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis CCutaneous and Ocular Toxicology 2012; 31(3): 253 doi: 10.3109/15569527.2011.641197
25
J.J. Napal Lecumberri, C. Sedano Balbas, J. Cañal Villanueva, J.L. Hernández Hernández. Trombofilia y factores de riesgo vascular en la obstrucción venosa retinianaRevista Clínica Española 2013; 213(5): 229 doi: 10.1016/j.rce.2013.01.012
26
I. Sanlés González, J.J. Napal Lecumberri, R. Pérez-Montes, A. Cerveró Varona, A. Casado Rojo, J.L. Hernández Hernández. Retinal vein occlusion in patients under 50 years. Analysis of vascular risk factors, thrombophilia, carotid ultrasound findings and uncommon aetiologiesArchivos de la Sociedad Española de Oftalmología (English Edition) 2022; 97(8): 443 doi: 10.1016/j.oftale.2021.12.002
27
Hillary C. Stiefel, Laura J. Kopplin, Thomas Albini, Michael Chang, Sravanthi Vegunta, Eric B. Suhler. Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart ReviewOcular Immunology and Inflammation 2021; 29(3): 566 doi: 10.1080/09273948.2019.1687729
28
O. Leaman-Alcibar, F. López-Campos, J. Aller, Ana Calín-Lorca, E. Zatarain-Nicolás, M. F. Bande, A. Navarro-Martin. Handbook of Cancer and Immunology2023; : 1 doi: 10.1007/978-3-030-80962-1_339-1